Company Overview and News

56
The Hidden Bear Market

2018-10-15 seekingalpha - 2
While the S&P 500 is still just 6% from its recent all-time high, a growing number of constituents are in bear market territory.
PCG SEE FB FBHS NEM LEN LB MAS DLTR NWL WHR AOS BEN CAH GM GEC GE PHM LKQ KHC GNE WRK

108
Fed's Macro Approach To The Economy Is Incorrect - Cramer's Mad Money (10/11/18)

2018-10-12 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, October 11.
NIO PG TTWO LEN IDXX TEL ISRG NWL EXPD INTU AMZN PPG MU TSE AMAT TSLA ADSK CLX

35
5 Homebuilding ETFs for the Daring

2018-10-12 investorplace
In a bull market that has lasted as long as the current one, spotting laggards becomes increasingly easy. Homebuilding stocks and exchange-traded funds are among those laggards.
LOW HD AMZN DHI LEN

 
Is Lennar (LEN) Mulling Over the Divesture of Rialto Capital?

2018-10-10 zacks
Lennar Corporation (LEN - Free Report) is likely to sell its real estate investment management unit, Rialto Capital, to a private-equity firm, Stone Point Capital LLC, per the report by Wall Street Journal. However, Lennar’s spokesperson refrained from commenting on the same. In April, the Miami-based homebuilder had already indicated strategic alternatives to improve the future path of Rialto, to drive efficiencies and cash flow.
AWI AFI TOL LEN LEN.B

 
D.R. Horton (DHI) Stock Down Post Q4 Preliminary Results

2018-10-10 zacks
D.R. Horton, Inc.’s (DHI - Free Report) shares declined 3.1% yesterday, after the company delivered preliminary fiscal fourth-quarter 2018 results. The company, which is set to report fiscal fourth-quarter results on Nov 8, stated that homes closed in the quarter increased 11% to 14,674, lagging the Zacks Consensus Estimate of 15,084. For the full year, homes closed increased 13% to 51,857 and 14% in value to $15.
TOL LEN DHI LEN.B NCS

 
UPDATE 2-D.R. Horton sees 2018 homes sales below estimates

2018-10-09 reuters
(Reuters) - U.S. homebuilder D.R. Horton Inc (DHI.N) on Tuesday forecast fiscal 2018 home sales and orders below Wall Street estimates, as rising home prices and mortgage rates hurt ordinary Americans’ ability to borrow.
LEN LEN.B

1
Lennar (LEN) Banks on Robust Housing Demand at Babcock Ranch

2018-10-08 zacks
Lennar Corporation (LEN - Free Report) announced that it will develop a new golf and country club community, Babcock National, situated northeast of Founders Square across Lake Babcock. The community will be located in the master-planned development in southwest Florida, Babcock Ranch. Through Babcock National, Lennar will offer 18 home designs, a mix of multi-family and single-family homes, with its signature Everything's Included program that offers a high level of standard features, which are already included in the price of the homes.
CCS LEN PHM DHI LEN.B

 
Trade of the Day: Mosaic Company (MOS)

2018-10-06 investorplace
To receive further updates on this Mosaic Company (NYSE:MOS) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of Power Options Weekly today.
MOS LEN DTK LEN.B

 
Lennar: Wait For It

2018-10-05 seekingalpha
Lennar's stock price is currently in an ugly uptrend as building permits are starting to slow while rates continue to climb.
LEN LEN.B

5
A Sober Look At Housing In The Middle Of All The Chaos

2018-10-05 seekingalpha
While the stock market continues to hit new all-time highs, the volatility in interest rate explodes, and political theatrics consume most media outlets, the housing market has had a very stealth slowdown that should start to be a cause for concern. The housing market has gone from a "yellow light" to a "red light" based on the recent data, and the housing-related equities support that view with the iShares U.
LOW HD KBH TOL DHI LEN ITB

69
3 Big Stock Charts for Thursday: Lennar, Kinder Morgan and International Paper

2018-10-05 investorplace - 1
Wednesday was the second winning day for the S&P 500 this week, but like the other two trading sessions, it has been a struggle. All the indices once again peeled back from intraday highs, with the bulls unwilling to keep the pressure on through the closing bell.
BAC IP KMI LEN INPAP AMD KMR KMRFZ CVB

35
Breakdowns In 10 And 30-Year Treasuries Wednesday

2018-10-04 seekingalpha
The 10-year Treasury's yield closed today at 3.16%, and depending on the source you listen to, 3.16% represents the highest yield since 2011 or 2008.
TOL AMZN LEN

121
5 Top Stock Trades for Thursday — What Happened to Bonds?

2018-10-03 investorplace - 1
While major U.S. indices closed near flat today, we saw gold prices fall and steep declines in volatility and bonds. It was interesting behavior for these safe-haven and market measurement securities to tumble in such a fashion. Let’s lead off with that in our top stock trades.
BAC AMZN JPM TLT CAT GOOGL TWTR LEN AMD GOOG

133
Century Aluminum, Lennar Dive into Wednesday’s 52-Week Low Club

2018-10-03 247wallst
October 3, 2018: Here are four stocks trading with heavy volume among 121 equities making new 52-week lows in Wednesday’s session. On the NYSE decliners led advancers by about 1.45 to 1, and on the Nasdaq, advancers led decliners by about 1.6 to 1.
GOV SIR LEN RAD CENX LEN.B GOVNI

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to LEN / Lennar Corp. on message board site Silicon Investor.

Hemp based foods from Naturally Splendid Enterprises Ltd. Hemp based foods from Naturally Splendid Enterprises Ltd. Hemp based foods from Naturally Splendid Enterprises Ltd. Ad Astra - An open Memorial for fallen SI members Ad Astra - An open Memorial for fallen SI members Ad Astra - An open Memorial for fallen SI members
LEN: Lennar Corporation LEN: Lennar Corporation LEN: Lennar Corporation The Millennium Crash The Millennium Crash The Millennium Crash
KMI- a fallen high dividend yielder - for how long? KMI- a fallen high dividend yielder - for how long? KMI- a fallen high dividend yielder - for how long? E-Cat Device: Low Energy Nuclear Reaction(LENR) Devices E-Cat Device: Low Energy Nuclear Reaction(LENR) Devices E-Cat Device: Low Energy Nuclear Reaction(LENR) Devices
IPD.V - International Parkside Products(Lenspen) IPD.V - International Parkside Products(Lenspen) IPD.V - International Parkside Products(Lenspen) Valens GroworksCorp VGW Valens GroworksCorp VGW Valens GroworksCorp VGW
GTI.C - Glenbriar Technologies GTI.C - Glenbriar Technologies GTI.C - Glenbriar Technologies Agilent Technologies (A) Agilent Technologies (A) Agilent Technologies (A)
CUSIP: 526057104